Avitide Overview

  • Founded
  • 2012
Founded
  • Status
  • Private
  • Employees
  • 35
Employees
  • Latest Deal Type
  • Series H
  • Latest Deal Amount
  • $10M
Latest Deal Amount
  • Investors
  • 12

Avitide General Information

Description

Developer of a molecule-specific bio-pharmaceutical affinity purification technology designed to improve drug safety and establish bio similarity. The company's technology focuses on purifying therapeutic proteins, and uses rapid development of chromatography resins via chemical synthesis, enabling partners to achieve faster bioprocess development timelines, reduced program risk, predictable commercial scalability, and lower cost of manufacturing for batch and continuous operations.

Contact Information

Website
www.avitide.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Services
Other Industries
Discovery Tools (Healthcare)
Biotechnology
Primary Office
  • 16 Cavendish Court
  • Lebanon, NH 03766
  • United States
+1 (603) 000-0000

Avitide Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Avitide Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC (Series H) 23-Oct-2019 $10M 000.00 00000 Completed Generating Revenue
7. Later Stage VC (Series G) 23-Aug-2018 00.000 000.00 00000 Completed Generating Revenue
6. Later Stage VC (Series F) 02-Jan-2018 000 000.00 00000 Completed Generating Revenue
5. Later Stage VC (Series E) 26-Jun-2017 0000 000.00 0000 Completed Generating Revenue
4. Later Stage VC (Series D) 12-Sep-2016 000 000.00 000.00 Completed Generating Revenue
3. Later Stage VC (Series C) 06-Aug-2015 00.00 000.00 000.00 Completed Generating Revenue
2. Early Stage VC (Series B) 09-Jun-2014 $3.44M $4.89M 000.00 Completed Startup
1. Early Stage VC (Series A) 04-Mar-2013 $1.45M $1.45M 00.000 Completed Startup
To view Avitide’s complete valuation and funding history, request access »

Avitide Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series H 000,000 00.000000 000.00 000.00 00 000.00 0.000
Series G 000,000 00.000000 000.00 000.00 00 000.00 0.000
Series F 000,000 00.000000 000.00 000.00 00 000.00 0.000
Series E 000,000 00.000000 000.00 000.00 00 000.00 00.000
Series D 000,000 00.000000 00.00 00.00 00 00.00 0.000
Series C 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series B 918,450 $0.000100 $3.74 $3.74 1x $3.74 10.92%
Series A 783,422 $0.000100 $1.87 $1.87 1x $1.87 9.32%
To view Avitide’s complete cap table history, request access »

Avitide Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a molecule-specific bio-pharmaceutical affinity purification technology designed to improve drug safety and
Other Healthcare Services
Lebanon, NH
35 As of 2021
000.00
0000 0000-00-00
00000000000 000.00

000000 0

n ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in
0000000000000
Cambridge, United Kingdom
00 As of 0000
000.00
00.00 0000-00-00
000000000 000.00

00000000

nderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupid
0000000000000
Billerica, MA
00 As of 0000
00000
000 0000-00-00
000000&0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Avitide Competitors (23)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sphere Fluidics Venture Capital-Backed Cambridge, United Kingdom 00 000.00 000000000 000.00
000000000 00000000 Formerly VC-backed Billerica, MA 00 00000 000000&0 00000
00000000 000-00000 Corporate Backed or Acquired Fremont, CA 00 000.00 000000&0 000.00
000000000 Formerly VC-backed Seraing, Belgium 000 00.000 000000&0 00.000
000000000 Private Equity-Backed Billerica, MA 000 00000 000000000 - 00000
You’re viewing 5 of 23 competitors. Get the full list »

Avitide Executive Team (7)

Name Title Board Seat Contact Info
Kevin Isett Ph.D Co-Founder, Chief Executive Officer & Board Member
Scott Kennedy Vice President & Chief Financial Officer
Warren Kett Ph.D Co-Founder & Chief Scientific Officer
Dan Freymeyer Head, Business Development
Karol Lacki Ph.D Vice President of Technology Development
You’re viewing 5 of 7 executive team members. Get the full list »

Avitide Board Members (9)

Name Representing Role Since
Ajay Royan Mithril Capital Management Board Member 000 0000
Claudio Nessi Ph.D NeoMed Management Board Member 000 0000
Colin Greenspon JD Mithril Capital Management Board Member 000 0000
Ian Ratcliffe Sands Capital Board Member 000 0000
Kevin Isett Ph.D Avitide Co-Founder, Chief Executive Officer & Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »

Avitide Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Avitide Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Sands Capital Venture Capital Minority 000 0000 000000 0
Section 32 Venture Capital Minority 000 0000 000000 0
Mithril Capital Management Venture Capital Minority 000 0000 000000 0
NeoMed Management Venture Capital Minority 000 0000 000000 0
Angeli Parvi Angel Group Minority 000 0000 000000 0
You’re viewing 5 of 12 investors. Get the full list »